Neuroendocrine Cancer UK Launches Practice-Changing Grants
Neuroendocrine Cancer UK is thrilled to announce the launch of our Practice-Changing Grants initiative, which is part of our Advancing Research campaign. The grants are designed to identify practical solutions that significantly enhance the well-being and experiences...NEW PODCAST – Neuroendocrine Cancer and Quality of Life Research: Conversations with Prof. John Ramage
We are excited to present our latest podcast episode, where we delve into the intriguing world of quality-of-life research with a distinguished expert in the field, Professor John Ramage. Prof. Ramage is a consultant physician specialising in gastroenterology and...
Ancora – Humanising clinical trials with AI
We are thrilled to announce a development that brings renewed hope to the Neuroendocrine Cancer community. Ancora.ai, an innovative company at the forefront of medical technology, is transforming the landscape of clinical trial accessibility for patients with...